2097133-31-6

Methyl 4-(4-Chloro-6-methyl-2-pyrimidinyl)-1-methoxycyclohexanecarboxylate may be useful in the preparation of heterocyclyl aminopyrazoles as inhibitors of RET kinase for treatment of cancer.